PowerPoint Presentation Update on transplant-ineligible patients: Which regimens are best? Suzanne Lentzsch MD, PhD Columbia University, New York 1 Disclosures for Suzanne…
original article T h e n e w e ngl a nd j o u r na l o f m e dic i n e n engl j med 371;10 nejm.org september 4, 2014906 Lenalidomide and Dexamethasone in Transplant-Ineligible…
Sustained Minimal Residual Disease Negativity With Daratumumab in Newly Diagnosed Multiple Myeloma: MAIA and ALCYONEThis is a repository copy of Sustained Minimal Residual